Clinical trial
Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis
NCT00143819 · University of Medicine and Dentistry of New Jersey, Other · Terminated
Key facts
| NCT number | NCT00143819 |
|---|---|
| Title | Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis |
| Official title | Double-Blind, Bilateral, Vehicle-Controlled, Randomized Trial of Neuroskin Forte to Relieve Symptoms of Dry Skin |
| Lead sponsor | University of Medicine and Dentistry of New Jersey, Other |
| Collaborators | AVVAA World Healthcare Products, Inc. Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Psoriasis, Eczema |
| Intervention type | Drug |
| Interventions | Neuroskin Forte, Placebo Application |
| Enrollment | 13 |
| Start date | Sep 1, 2005 |
| Primary completion | Feb 1, 2010 |
| Completion | Feb 1, 2010 |
| First posted | Sep 2, 2005 |
| Last update posted | Apr 25, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: